Literature DB >> 28943217

Pyrotinib shows activity in metastatic breast cancer.

Elizabeth Gourd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28943217     DOI： 10.1016/S1470-2045(17)30755-6

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

Review 1.  Targeted therapeutic options and future perspectives for HER2-positive breast cancer.

Authors:  Jiani Wang; Binghe Xu
Journal:  Signal Transduct Target Ther       Date:  2019-09-13

2.  Tyrosine Kinase Inhibitors in the Combination Therapy of HER2 Positive Breast Cancer.

Authors:  Xue Yang; Dapeng Wu; Shengli Yuan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

3.  Pathological Complete Response from Pyrotinib Combined with Trastuzumab, Paclitaxel and Cisplatin in a Postpartum Woman with HER2-Positive Locally Advanced Breast Cancer: A Case Report.

Authors:  Lina He; Fengchun Zhang; Yue Ma; Li Zuo; Yingchun Xu
Journal:  Onco Targets Ther       Date:  2020-08-27       Impact factor: 4.147

4.  Gastric Cancer Harboring an ERBB3 Mutation Treated with a Pyrotinib-Irinotecan Combo: A Case Study.

Authors:  Kailin Ding; Xian Chen; Yong Li; Wenzhu Li; Yongsong Ye; Tingting He; Wenjing Wang; Haibo Zhang
Journal:  Onco Targets Ther       Date:  2021-01-18       Impact factor: 4.147

5.  Development and validation of a nomogram in survival prediction among advanced breast cancer patients.

Authors:  Jianli Zhao; Yaping Yang; Danmei Pang; Yunfang Yu; Xiao Lin; Kai Chen; Guolin Ye; Jun Tang; Qian Hu; Jie Chai; Zhuofei Bi; Linxiaoxiao Ding; Wenjing Wu; Yinduo Zeng; Xiujuan Gui; Donggeng Liu; Herui Yao; Ying Wang
Journal:  Ann Transl Med       Date:  2020-11

6.  The Synergistic Effects of Pyrotinib Combined With Adriamycin on HER2-Positive Breast Cancer.

Authors:  Chaokun Wang; Shuzhen Deng; Jing Chen; Xiangyun Xu; Xiaochen Hu; Dejiu Kong; Gaofeng Liang; Xiang Yuan; Yuanpei Li; Xinshuai Wang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

7.  Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation.

Authors:  Claudia Cava; Gloria Bertoli; Isabella Castiglioni
Journal:  Future Virol       Date:  2021-07-20       Impact factor: 1.831

8.  Multiple Administrations of Itraconazole Increase Plasma Exposure to Pyrotinib in Chinese Healthy Adults.

Authors:  Yueyue Liu; Qian Zhang; Chao Lu; Wei Hu
Journal:  Drug Des Devel Ther       Date:  2021-06-10       Impact factor: 4.162
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.